• ISSN: 2349-6002
  • UGC Approved Journal No 47859
Author Login IJIRT Partner Network (IPN) Login

Insulin Paving Way to Breast Cancer and Its Current Clinical Therapies

  • Unique Paper ID: 158525
  • Volume: 9
  • Issue: 9
  • PageNo: 709-713
  • Abstract:
  • The world booms with insulin and its alarming diseases. Insulin is secreted from islets of Langerhans and regulates various metabolic processes, facilitates glucose uptake, and promotes cell division. Several protooncogenes are mutated to an oncogene by various signaling pathways in which insulin paves a major role in increasing the risk for initiation of developing varied solid tumors, especially in larger women’s diabetic populations. Insulin involves mainly in two signaling pathways include PI3K and MAPK pathways. Activation of these pathways leads to glucose and lipid homeostasis, inhibition of the proapoptotic pathway, translocation of GLUT-4 receptor to membrane and fat to increase glucose uptake, and inhibition of glycolysis and gluconeogenesis. Among Luminal A & B and TNBC types PI3K and MAPK pathway mainly involves in the proliferation of survival translation, these are regulated by tumor suppressor genes such as p53, PTEN, BRCA1 & BRCA2.
email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 9
  • PageNo: 709-713

Insulin Paving Way to Breast Cancer and Its Current Clinical Therapies

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry